ArticleACS applied materials & interfaces2026
Nanoarchitectonics of Metal-Organic Framework Platforms for Enhanced Enzyme Delivery with Preserved Activity.
Article in ACS applied materials & interfaces, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The targeted delivery of biomacromolecules remains a critical challenge due to their intrinsic instability, limited permeability across biological barriers, and susceptibility to degradation. Herein, we report postsynthetic enzyme encapsulation in reaction-mechanism-guided metal-organic framework nanocarriers (MOF NCs), enabling selective loading, controlled release, and preserved biological function. The MOF NCs were synthesized via coordination-driven assembly, yielding hybridized porous architectures with high colloidal stability in aqueous media. Enzyme encapsulation was accomplished through nondisruptive interactions, including hydrogen bonding, ionic interactions, covalent anchoring, or van der Waals interactions. The structural integrity of β-Dextranase and endo-1,4-β-mannanase, enzymes known to disrupt oral biofilms, was maintained throughout encapsulation and release, as confirmed by circular dichroism spectroscopy. Environmentally responsive enzyme release was triggered under mildly acidic or alkaline conditions, driven by ligand exchange and hydrolysis at the zinc coordination centers, leading to nanocarrier disassembly and subsequent enzymatic activation. The MOF NCs exhibited excellent biocompatibility and preserved enzyme activity comparable to free enzymes at acidic and basic pH values, demonstrating their potential for targeted therapeutic applications at otherwise inaccessible biological sites.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.